![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
USPTO Grants Acurx Pharmaceuticals New Patent for Ibezapolstat to Treat CDI While Reducing Recurrence of Infection and Improving Health of the Gut Microbiome PR Newswire STATEN ISLAND, N.Y., July...
Acurx Pharmaceuticals, Inc. to Discuss Second Quarter 2024 Financial Results on August 9, 2024 Conference Call and Provide Business Update PR Newswire STATEN ISLAND, N.Y., July 16, 2024 STATEN...
Acurx Pharmaceuticals Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results for CDI at Scientific Conference PR Newswire STATEN ISLAND, N.Y., July 15, 2024 Additional analyses of...
NEW YORK, June 06, 2024 (GLOBE NEWSWIRE) -- FMW Media's New to The Street announces the broadcasting of its national business TV show airing on Bloomberg TV as sponsored programming tonight...
Acurx Announces Successful FDA End-of-Phase 2 Meeting and Phase 3 Readiness for Ibezapolstat in the Treatment of C. difficile Infection PR Newswire STATEN ISLAND, N.Y., May 15, 2024 Agreement...
U.S. index futures are virtually flat in pre-market trading this Wednesday, with Wall Street awaiting April’s consumer price index data. At 7:18 AM, Dow Jones futures (DOWI:DJI) were up 3...
Period † | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
4 | 2.11 | 3.33070244672 | 63.35 | 65.46 | 61.38 | 38 | 61.70846667 | DR |
12 | 7.86 | 13.6458333333 | 57.6 | 65.46 | 57.6 | 24 | 59.81156673 | DR |
26 | 17.11 | 35.3877973113 | 48.35 | 65.46 | 47.55 | 85 | 51.29941524 | DR |
52 | 20.66 | 46.1160714286 | 44.8 | 65.46 | 44.48 | 4348 | 45.60534336 | DR |
156 | 22.75 | 53.2662140014 | 42.71 | 65.46 | 40.89 | 3071 | 45.44045136 | DR |
260 | 22.75 | 53.2662140014 | 42.71 | 65.46 | 40.89 | 3071 | 45.44045136 | DR |
Symbol | Price | Vol. |
---|---|---|
HBSA3Hidrovias DO Brasil SA | R$ 3.55 (-1.39%) | 5.04M |
GGPS3GPS Participacoes e Empreendimentos S.A. | R$ 16.91 (-1.91%) | 3.49M |
LOGG3LOG Commercial Properties Participacoes SA | R$ 21.32 (0.09%) | 569.1k |
FRAS3Fras le Sa | R$ 18.98 (-1.86%) | 551.3k |
PLPL3Plano & Plano Desenvolvimento Imobiliario S.A. | R$ 11.35 (0.44%) | 543.6k |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions